Category: Medicine

Breakout session summarizes key areas that will affect all aspects of the industry. On Day 1 of the Trade & Channel Strategies conference in Philadelphia, it’s strong start continued with a presentation on multiple factors of the Inflation Reduction Act (IRA) that will affect businesses throughout the US. The presentation featured Douglas Bock, Partner, Archbow […]

The FDA previously granted the application for Padcev (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) with priority review and breakthrough designation for patients with locally advanced or metastatic urothelial cancer. The FDA has approved Padcev (enfortumab vedotin-ejfv; Astellas Pharma and Seagen [now owned by Pfizer]) plus Keytruda (pembrolizumab; Merck) for patients with locally advanced or metastatic urothelial […]